PrednisoneDoxorubicinCyclophosphamideAntineoplastic Combined Chemotherapy ProtocolsVincristineEtoposideBleomycinPrednisoloneLomustineAntibodies, Monoclonal, Murine-DerivedVinblastineMethotrexateLymphoma, Non-HodgkinMelphalanDrug Administration ScheduleTreatment OutcomeGlucocorticoidsVinca AlkaloidsAsparaginaseAntineoplastic Agents, PhytogenicRemission InductionLymphoma, Large B-Cell, DiffuseMitoxantroneProcarbazineCombined Modality TherapyHodgkin DiseaseMechlorethamineChlorambucilDrug ResistanceAzathioprineDaunorubicinImmunosuppressive AgentsDisease-Free SurvivalAntineoplastic AgentsSurvival AnalysisPrecursor Cell Lymphoblastic Leukemia-LymphomaMultiple MyelomaSurvival RateP-GlycoproteinCytarabineDexamethasoneVindesineLeukemia P388Drug Therapy, CombinationDacarbazineFollow-Up StudiesAnti-Inflammatory AgentsDrug Resistance, MultipleLymphoma, FollicularCarmustineLeukemia, LymphoidTime FactorsRhabdomyosarcomaRecurrenceDrug Resistance, NeoplasmCyclosporineDose-Response Relationship, DrugTeniposideColor TherapyPrognosis6-MercaptopurineThalidomideNeoplasm StagingAdministration, OralClinical Trials as TopicCyclosporinsLymphoma, B-CellDactinomycinIfosfamideOligodendrogliomaVerapamilLymphomaColchicineMycophenolic AcidThrombocytopeniaCarcinoma, Small CellProspective StudiesCatharanthusActuarial AnalysisPyrazinesFluoxymesteroneAdrenal Cortex HormonesAntibodies, MonoclonalMethylprednisoloneBoronic AcidsHematologic DiseasesKidney TransplantationCisplatinAntibiotics, AntineoplasticChemotherapy-Induced Febrile NeutropeniaSemustinePodophyllotoxinGraft RejectionLeukemia L1210TacrolimusSarcoma, EwingTransplantation, AutologousWilms TumorRandom AllocationSalvage Therapy